T1	Participants 34 74	patients operated on for hip prosthesis]
T2	Participants 598 730	211 patients of both sexes candidates to receive total hip arthroplasty and presenting at least one major thromboembolic risk factor
T3	Participants 2191 2237	patients undergoing major orthopaedic surgery.
